ICAM1 and obstructive sleep apnea syndrome: In summary, given the strong association between elevated ICAM-1 levels and cardiovascular events in OSA patients, ICAM-1 could serve as a valuable biomarker for identifying individuals at higher risk of adverse outcomes.